首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis, antibacterial evaluation and QSAR studies of 7-(4-(5-aryl-1,3,4-oxadiazole-2-yl)piperazinyl) quinolone derivatives.
【24h】

Synthesis, antibacterial evaluation and QSAR studies of 7-(4-(5-aryl-1,3,4-oxadiazole-2-yl)piperazinyl) quinolone derivatives.

机译:7-(4-(5-芳基-1,3,4-恶二唑-2-基)哌嗪基)喹诺酮衍生物的合成,抗菌评估和QSAR研究。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 7-[4-(5-aryl-1,3,4-oxadiazole-2-yl)piperazinyl] quinolones (I-XXI) were synthesized using an appropriate synthetic route and characterized by elemental and spectral analysis. The antibacterial activities of all the synthesized compounds were evaluated against identifiable bacterial strains. Compounds III, IV, VII, VIII, IX, X, XI, XV, &XVIII showed better activity than parent compound against all the selected strains. QSAR study on the synthesized molecules tested for their antibacterial activity was performed using multiple linear regression method. Generated models revealed a decrease in HOMO energy as favorable descriptor for determining and predicting the antibacterial activity of the synthesized compounds. Further, the developed models were cross validated using LOO method for their predictive nature.
机译:使用适当的合成路线合成了一系列7- [4-(5-芳基-1,3,4-恶二唑-2-基)哌嗪基]喹诺酮(I-XXI),并通过元素和光谱分析进行了表征。评价了所有合成化合物对可鉴定细菌菌株的抗菌活性。化合物III,IV,VII,VIII,IX,X,XI,XV和XVIII显示出比母体化合物更好的针对所有选定菌株的活性。使用多元线性回归方法对合成分子的抗菌活性进行了QSAR研究。生成的模型表明,HOMO能量的降低是确定和预测合成化合物抗菌活性的有利指标。此外,使用LOO方法对开发的模型的预测性质进行了交叉验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号